tiprankstipranks
Trending News
More News >
Cardiol Therapeutics (CRDL)
NASDAQ:CRDL
US Market
Advertisement

Cardiol Therapeutics (CRDL) Ownership - Who Owns Cardiol Therapeutics?

Compare
585 Followers

Cardiol Therapeutics (CRDL) Ownership Overview

4.17%0.06%0.17%1.44%94.15%
0.17% Other Institutional Investors
1.44% ETFs
94.15% Public Companies and Individual Investors
The ownership structure of Cardiol Therapeutics (CRDL) stock is a mix of institutional, retail, and individual investors. Approximately 1.67% of the company’s stock is owned by Institutional Investors, 4.17% is owned by Insiders, and 94.15% is owned by Public Companies and Individual Investors.
The ownership structure of Cardiol Therapeutics (CRDL) stock is a mix of institutional, retail, and individual investors. Approximately 0.23% of the company’s stock is owned by Institutional Investors, 4.17% is owned by Insiders, and 1.44% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 23, 2025
xxxxxxxxxxxxx
$50000
Oct 23, 2025
xxxxxxxxxxxxx
$100000
Dec 27, 2024
xxxxxxxxxxxxx
$21721
Dec 25, 2024
xxxxxxxxxxxxx
$24727

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,244,500Insider1.49%1,294,280
1,012,080Insider1.21%1,052,563
659,726Institution0.79%686,115
547,116Institution0.65%569,001
536,613Insider0.64%558,078
259,309Insider0.31%269,681
135,900Insider0.16%141,336
133,334Insider0.16%138,667
133,334Insider0.16%138,667
52,435Institution0.06%54,532

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
52,435Institution0.06%54,532

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Cardiol Therapeutics (CRDL)?
According to the latest TipRanks data, approximately 0.17% of the company's stock is held by institutional investors, 4.17% is held by insiders, and 94.15% is held by retail investors.
    What percentage of Cardiol Therapeutics (CRDL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.17% of Cardiol Therapeutics (CRDL) stock is held by institutional investors.
      What percentage of Cardiol Therapeutics (CRDL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 94.15% of Cardiol Therapeutics (CRDL) stock is held by retail investors.
        Who owns the most shares of Cardiol Therapeutics (CRDL)?
        David Elsley owns the most shares of Cardiol Therapeutics (CRDL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis